Development
Elevance Health, Inc.
ELV
$393.36
$8.712.26%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 5.99B | 6.00B | 6.31B | 6.09B | 5.89B |
| Total Depreciation and Amortization | 1.06B | 1.20B | 1.22B | 1.18B | 1.08B |
| Total Amortization of Deferred Charges | 685.00M | 599.00M | 599.00M | 599.00M | 599.00M |
| Total Other Non-Cash Items | 864.00M | 1.04B | 426.00M | 429.00M | 407.00M |
| Change in Net Operating Assets | -535.00M | 683.00M | 3.27B | 4.03B | 423.00M |
| Cash from Operations | 8.06B | 9.51B | 11.83B | 12.33B | 8.40B |
| Capital Expenditure | -1.30B | -1.27B | -1.25B | -1.20B | -1.15B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1.55B | -1.60B | -1.69B | -2.23B | -649.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.72B | -1.39B | -1.87B | -2.74B | -2.76B |
| Cash from Investing | -5.57B | -4.25B | -4.81B | -6.17B | -4.56B |
| Total Debt Issued | 2.91B | 4.35B | 4.07B | 7.38B | 5.67B |
| Total Debt Repaid | -2.25B | -3.97B | -3.90B | -5.96B | -3.57B |
| Issuance of Common Stock | 152.00M | 142.00M | 147.00M | 149.00M | 182.00M |
| Repurchase of Common Stock | -2.78B | -2.42B | -2.52B | -2.50B | -2.41B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.40B | -1.35B | -1.31B | -1.27B | -1.23B |
| Other Financing Activities | 7.00M | 30.00M | 36.00M | 38.00M | 41.00M |
| Cash from Financing | -3.35B | -3.21B | -3.47B | -2.17B | -1.32B |
| Foreign Exchange rate Adjustments | -1.00M | 0.00 | -2.00M | -9.00M | -14.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -861.00M | 2.05B | 3.54B | 3.98B | 2.51B |